Skip to content

Clinical trials

Observational Metabolism, Inborn Errors trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Metabolism, Inborn Errors Phase: Observational Country / region: United States Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20041
20062
20071
20121
20141
20151
20161
20171
20181
20191
20201
20212
20221
20241
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Recruiting6
Terminated3
Unknown status3
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Center for Research Resources (NCRR)5
National Human Genome Research Institute (NHGRI)5
Alnylam Pharmaceuticals1
Amicus Therapeutics1
Celgene Corporation1
Duke University1
Fairview University Medical Center1
HemoShear Therapeutics1
JCR Pharmaceuticals Co., Ltd.1
ModernaTX, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Metabolism, Inborn Errors25
Genetic Diseases, Inborn11
Metabolic Diseases10
Lysosomal Storage Diseases6
Brain Diseases, Metabolic, Inborn5
Rare Diseases5
Sphingolipidoses4
Brain Diseases3
Brain Diseases, Metabolic3
Central Nervous System Diseases3

Trials

Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.